News

10 March 2017

The TBDO will participate in the Bio-Europe 2017 in Barcelona

BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies: a great opportunity for partnering, networking and promoting CRG technologies.

Read More

24 February 2017

Size matters... and structure too!

CRG Researchers developed Global Score, a method that allows, for the first time, to predict protein interactions with long non-coding RNAs.

3 February 2017

CaixaImpulse 2017 - New call for projects now open

Aimed at researchers in the fields of Healthcare and Life Sciences, interested in transferring research assets from the lab to society and the market.

Projects may be submitted from 1 February to 15 March 2017

Read More

27 January 2017

MicrobioMx wins the S2B Concept Challenge

MicrobioMx, a project led by CRG researchers Toni Gabaldon and Pedro González, wins the Science to Business (S2B) Concept Challenge 2016.

27 January 2017

New public-private initiative to develop a new therapy against aterosclerosis

The project - which has just received 700,000 euros in the Spanish 2016 Retos-Colaboracion call- is led by biotech Iproteos with the participation of the Biomedical Research Institute of Barcelona...

22 November 2016

Local company Made of Genes in ‘El cazador de cerebros’

Saturday November 5th, Made of Genes was in the TV program ‘El cazador de cerebros - ¿Querrías saber tu destino genético?’ broadcasted by TVE La 2.

View More

13 October 2016

CRG Proof of Concept: Commercialization Gap Fund (CGF)

Deadline : 01/11/2016 (Last days to apply!)

Please send your Full Proposal (max. 10 pages) under the following schemes:

  • MIDI - Up to 6 months and 35 kEUR
  • MAXI - Up to 12 months and 75 kEUR

Read More

7 October 2016

Science to Business (S2B) Concept Challenge

Deadline : 01/11/2016 (Last days to apply!)

Don't miss out on your opportunity to see your innovation go from conception to success. Send your application (max. 10 slides) addressing the following guidelines:

  • About You 1 slide
  • Technology 2–3 slides
  • Potential Applications 1-2 slides
  • Path to Market 1-2 slides
  • Risks 1 slide
  • Plan 1 slide

Read More

20 September 2016

Strengthening gene therapy for Huntington’s disease

A single injection of a new treatment has reduced the activity of the gene responsible for Huntington’s disease for several months in a trial in mice.